Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2015 · 10-Q
Revenue$114.16M$114.16M+19.5% vs Q3 2014 Net Income$24.29M$24.29M−23.2% vs Q3 2014 EPS Diluted$0.65$0.65−23.5% vs Q3 2014 Gross Profit$79,380,000+16.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$30,776,000−11.9% Free Cash Flowderived$25,852,000−15.7% Margins · derivedGross margin69.5%−1.7 pt vs Q3 2014
Operating margin34.5%−13.4 pt vs Q3 2014
Net margin21.3%−11.8 pt vs Q3 2014
ended Mar 31, 2015 · filed May 11, 2015 · 41 d after period end